Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10900278 | Cancer Letters | 2005 | 11 Pages |
Abstract
Hepatocyte growth factor activator inhibitor type-1 (HAI-1) is an integral-membrane proteinase inhibitor. In this study, we examined the effects of HAI-1 on human glioblastoma cells. Two glioblastoma cell lines (YKG-1, U251) were stably transfected with expression plasmid harboring mature membrane-form or truncated secreted-form HAI-1. Culture characteristics were not altered by the expression of HAI-1, whereas in vitro invasiveness of U251 was suppressed. On the other hand, the expression of membrane-form HAI-1 resulted in significantly enhanced tumorigenicity of both cell lines in vivo. In contrast, secreted-form HAI-1 did not promote the tumorigenicity. These results suggest that HAI-1 may play complex roles in progression of glioblastoma cells, and membrane-form HAI-1 may mediate an undefined important signaling in the cells.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Shiro Miyata, Shunro Uchinokura, Tsuyoshi Fukushima, Ryouichi Hamasuna, Hiroshi Itoh, Yutaka Akiyama, Shinichi Nakano, Shinichiro Wakisaka, Hiroaki Kataoka,